Dow Jones 30 Stocks SEC Filings — October 16, 2026

Q3 net income $1.917B (+2% YoY) and core income $1.947B (+4%); combined ratio improved to 86.8% from 87.3%, with year-to-date combined ratio down 6.9 points driven by 5.4 points of lower catastrophe losses

$1.8B returned to shareholders in Q3 including $1.508B of buybacks, supporting per-share earnings growth (diluted EPS $9.04 vs $8.24)

Personal Insurance net written premiums fell 7% in Q3 and 8% year-to-date, with segment income down 12.5% YoY to $706M despite net investment income up 7.9%

Nine-month net income up 53.9% to $5.836B, but driven by the $2.388B Canadian divestiture and a 12.1% decline in claims expenses, so underlying earnings momentum is weaker than the headline suggests

Shareholders' equity down 11.9% year-to-date to $28.995B on a $7.063B accumulated other comprehensive loss; book value per share fell 6% YTD, pressuring the valuation case despite buybacks

President & CEO Furner sold 7,089 shares at $120.33 (~$853K) and 6,036 at $120.93 (~$730K) under a 10b5-1 plan, holding 634,790 shares afterward; executive sales continue at $115-$121 across three insiders

EVP Nicholas Christopher James sold 2,900 shares in total (~$350K) at $120.33-$120.95 under a 10b5-1 plan, retaining 563,353 shares; the sales are pre-planned and weak as a conviction signal

CEO Hill Elliott had 5,635 Class B shares withheld for taxes at $35.33 (~$199K), leaving 368,095 shares; this is a tax withholding event, not an open-market sale, and is neutral

Four directors (Hess, Flaherty, Oppenheimer, Johnson) received routine RSU grants of 29-65 units; no open-market buying or selling was reported, so no insider conviction signal is present

All twelve director nominees elected, Say on Pay approved at 1.514B for vs 138M against (about 92% support), and all three shareholder proposals failed, a management-favorable outcome

JPMorgan's amended 13G reports 44.1M 3M shares (8.5% of the class) as of 9/30/2026 under Rule 13d-1(b), a passive disclosure with no control intent and no near-term catalyst

Personal Insurance net written premiums down 7% in Q3 and 8% YTD (Q3 premiums $4.138B, down 5.8%), a decline masked by flat consolidated premiums of $11.480B; this is a core-franchise deterioration

Shareholders' equity down 11.9% YTD to $28.995B, book value per share down 6% YTD, and net unrealized investment losses of $8.049B pre-tax (up from $1.862B at year-end 2025) driven by higher rates

A $295M addition to asbestos reserves in Q3 offset favorable prior-year development of $234M; reserve adequacy remains a tail-risk item

Q3 realized investment losses of $(34)M versus $27M of gains a year earlier; nine-month G&A up 2.4% to $4.688B and interest expense up 12.3% to $347M, pressuring margins

Q3 total revenues down 0.5% YoY to $12.412B, and Personal Insurance segment income down 12.5%, indicating the buyback-supported EPS growth is not matched by top-line expansion

Three executives (CEO Furner, EVP Watkins, EVP Nicholas) sold roughly $1.5M in aggregate in the period, all at $115-$121; although 10b5-1 plan-driven, the cluster may read as negative sentiment to the market

The special-meeting threshold proposal drew 608.5M for vs 1,043.7M against (about 37% support), and the charitable contributions proposal only 67.6M for; sustained minority dissent on governance may signal investor pressure

Year-to-date combined ratio improved 6.9 points, with quarterly ratio at 86.8% vs 87.3%; if catastrophe losses normalize, underwriting margins could expand further while buybacks ($1.508B in Q3) reduce share count

The $2.388B Canadian divestiture provides balance-sheet capacity; with $1.8B returned in Q3, management has demonstrated capital return capacity that could compound per-share value if the book value stabilizes

$8.049B of unrealized losses on the bond portfolio would reverse with lower rates, so any rate decline would rebuild book value and equity, an asymmetric upside for shareholders

With all management proposals approved and Say on Pay at about 92% support, governance appears stable; the 37% support for the special-meeting threshold proposal is a dissent signal that activists may exploit if sentiment shifts

CEO Elliott retains 368,095 shares after a tax-withholding event rather than a sale, a neutral-to-positive signal of continued alignment with shareholders at a $35 share price

JPMorgan's 8.5% passive stake (44.1M shares) is a large institutional position; the diversified ownership base across JPMorgan affiliates can provide liquidity support, though this is a passive position with no activist intent

Travelers' flat consolidated premiums ($11.480B) mask a Personal Insurance decline of 7% offset by Business Insurance growth of 3%; the shift toward commercial lines is a theme for P&C carriers, with Personal lines under pricing or competitive pressure [IMPLICATION: favors carriers with commercial exposure over personal-lines-heavy peers]

Rising rates produced $8.049B of unrealized investment losses for Travelers, a sensitivity that affects equity and book value across insurers; the theme favors carriers with shorter-duration portfolios or hedging programs [IMPLICATION: watch duration positioning in P&C and financial-sector peers]

Travelers ($1.8B returned in Q3, $1.508B buybacks) and Walmart's sustained open-market and 10b5-1 activity show blue-chip companies continuing to return capital despite flat or declining fundamentals; this supports per-share metrics but can mask underlying growth weakness [IMPLICATION: scrutinize EPS growth quality against revenue trends]

Walmart's three executives sold under pre-arranged plans at $115-$121, while Goldman and Nike filings showed routine grants and withholding; the prevalence of plan-based selling makes insider signals less informative than discretionary transactions [IMPLICATION: discount 10b5-1 sales as conviction indicators]

P&G shareholders showed about 37% support for governance reform (special-meeting threshold) while rejecting other proposals; this pattern of moderate dissent without success is common among large-cap issuers and merits monitoring for escalation [IMPLICATION: track proxy voting trends in Dow constituents]

Personal Insurance premiums down 8% YTD; watch whether Q4 results show stabilization or continued decline and whether rate actions offset volume loss (next quarterly report, date not in filings)

The $295M Q3 addition warrants monitoring for further strengthening in future reserve reviews

Watch the unrealized loss position ($8.049B) against interest-rate moves; a reversal would materially improve equity (next 10-Q or 8-K filings)

Monitor whether the CEO and EVPs continue selling at $115-$121 and whether additional executives join; a broadening of sales would strengthen the negative signal

Withholding at $35.33 reflects a depressed share price; monitor for discretionary buying or selling by Elliott as a sentiment marker

The 37% special-meeting threshold support suggests pressure for proxy access reform; watch for shareholder resubmissions in future proxy seasons (next annual meeting, date not in filings)

JPMorgan's 8.5% stake is a sizeable passive position; any amendment or rise above 10% would trigger further filings and merit attention